Industry Insights

  1. Trailblazing Clinical Drug Development In Dermatology 1/6/2026

    AI, imaging, and biomarkers are transforming trials, reducing subjectivity and improving sensitivity while enabling decentralized designs, faster timelines, and more precise insights.

  2. Clinical Research Trends And IRB Expectations For 2026 1/6/2026

    Oversight in 2026 requires adaptability as AI, consent standards, and regulatory uncertainty challenge sponsors and IRBs to balance ethics with innovation through proactive planning and collaboration.

  3. Medical Insight's Role In Early-Phase Clinical Development 1/6/2026

    Medical insight reduces risk, strengthens protocols, and accelerates timelines — enhancing safety, feasibility, and collaboration for successful trials and reliable outcomes.

  4. Why Early Medical Assessment Matters In Clinical Trials 1/6/2026

    Early medical assessment reduces risk, improves patient selection, and avoids trial delays. Learn how starting early boosts compliance, speeds timelines, and protects participants and results.

  5. 2026: From Experimentation To Operational Reality In Clinical Research 1/6/2026

    Velocity Clinical Research COO Nick Spittal shares several trends he sees shaping up for 2026.

  6. Sales & Operations Planning for Small Teams: Aligning Clinical Supply 1/6/2026

    Small clinical teams don’t fail at S&OP from missing systems—they fail from unclear demand and decisions. Alignment comes from discipline, shared visibility, and acting on reality before timelines slip.

  7. How To Meet FDA Expectations For Hybrid And Decentralized Trial Oversight 1/5/2026

    Former FDA attorney Claire Davies shares strategies for meeting regulators' expectations for hybrid and decentralized clinical trial oversight.

  8. No Surprise Here: Experts Value Clinical Relevance Over Statistical Relevance 12/31/2025

    Experts weighed in: “Agree or disagree? Statistical significance is preferable to clinical relevance.”

  9. Trial Matching, Source Data, And More: How Clinical Researchers Used AI In 2025 12/30/2025

    Researchers reflect on the past year and share how they used AI for clinical research in 2025.

  10. CRO Industry Outlook 2026: The Next Stage Of Clinical Trial Transformation 12/30/2025

    Beroe research manager Mathini Ilancheran reflects on the advances in AI, the rise of APAC as a global trial hub, new regulatory expectations, and increasing scientific complexity and forecasts how they will impact CROs in the coming year.